As record levels of venture funding piles into startups, more companies may stay private rather than file for initial public offerings, according to venture capital database CB Insights and accounting firm KPMG.
Private companies raised more than $32.5 billion in the... Read more »
Biotechs everywhere are going public these days. You might have heard.
Approaching the traditional market lull in August, we’re up to nearly 40 life science IPOs in 2015, by my own count, with plenty more lined up. That’s more than half... Read more »
Companies in Colorado raised nearly $330.3 million from venture capital investors in the second quarter, a 185 percent jump from what they raised in the prior quarter, and while that increase might have locals smiling, a New York City-based private equity... Read more »
For some time, Uber and other Silicon Valley tech companies have been fighting off lawsuits and other claims that their labor practices are unfair to on-demand workers they classify as independent contractors rather than as employees.
The heat intensified this week... Read more »
[Updated 7/17/15, 7:40 a.m. See below.] There’s plenty of talk about a potential bubble in the market, whether in tech, biotech, or elsewhere. True or not, one fact that’s real is that there is plenty of money flowing into startups.... Read more »
Next week, the team at DigitalOcean will move into a 30,000-square-foot office, in the same building but twice the size of its current digs, as it ramps up with more funding in hand.
The New York-based company hosts cloud infrastructure, largely... Read more »
Sure, Pluto is 3 billion miles and nine years away, but the New Horizons spacecraft and the scientists behind the mission are actually quite close to home, if you live in Colorado.
New Horizons flew to within 7,800 miles of the... Read more »
The question is no longer whether we are in a tech bubble—we are—but rather what it all means for the future. And maybe the near future. Everyone seems to agree the market conditions are very different from 2000, but so what?... Read more »
The U.S. House of Representatives took a big step this morning toward major changes in the federal government’s relationship to biomedical research, funding, and regulation. The chamber passed the 21st Century Cures Act, a bill championed early on by a Democrat... Read more »
[Corrected 7/8/15, 3:48pm. See below.] Some people who’ve made it big in biotech drive fast cars. Some take outlandish vacations. Some don’t take any vacations at all. (I’m sure you know the type.) But for a few San Francisco... Read more »